CO5200840A1 - Combinacion de sustancias activas con clonidina - Google Patents
Combinacion de sustancias activas con clonidinaInfo
- Publication number
- CO5200840A1 CO5200840A1 CO00062317A CO00062317A CO5200840A1 CO 5200840 A1 CO5200840 A1 CO 5200840A1 CO 00062317 A CO00062317 A CO 00062317A CO 00062317 A CO00062317 A CO 00062317A CO 5200840 A1 CO5200840 A1 CO 5200840A1
- Authority
- CO
- Colombia
- Prior art keywords
- clonidine
- combination
- active substances
- compatible salts
- pharmacologically compatible
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Combinación de sustancias activas para el tratamiento del síndrome de piernas inquietas, que consta de clonidina o una de sus sales farmacológicamente compatibles y pramipexol o de una de sus sales farmacológicamente compatibles.Combinación de sustancias activas de acuerdo con la reivindicación 1, caracterizada porque la cantidad de clonidina o una de sus sales farmacológicamente compatibles por cada dosis individual, referida a la clonidina, corresponde a una administración por vía oral 0,01 a 1,0 mg, preferiblemente de 0,05 a 0,5 mg y de modo muy especialmente de 0,075 a 0,3 mg.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19938825A DE19938825A1 (de) | 1999-08-19 | 1999-08-19 | Wirkstoffkombination mit Clonidin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5200840A1 true CO5200840A1 (es) | 2002-09-27 |
Family
ID=7918574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00062317A CO5200840A1 (es) | 1999-08-19 | 2000-08-18 | Combinacion de sustancias activas con clonidina |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20020010201A1 (es) |
| EP (1) | EP1210081A2 (es) |
| JP (1) | JP2003507420A (es) |
| KR (1) | KR20020060163A (es) |
| AR (1) | AR025330A1 (es) |
| AU (1) | AU6440600A (es) |
| BR (1) | BR0013353A (es) |
| CA (1) | CA2376606A1 (es) |
| CO (1) | CO5200840A1 (es) |
| CZ (1) | CZ2002515A3 (es) |
| DE (1) | DE19938825A1 (es) |
| IL (1) | IL147741A0 (es) |
| MX (1) | MXPA02001138A (es) |
| NO (1) | NO20020793L (es) |
| PE (1) | PE20010642A1 (es) |
| PL (1) | PL353358A1 (es) |
| TR (1) | TR200200449T2 (es) |
| UY (1) | UY26293A1 (es) |
| WO (1) | WO2001013902A2 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| ATE480235T1 (de) | 2001-12-11 | 2010-09-15 | Univ Virginia | Verwendung von pramipexol zur behandlung von amyotrophischer lateralsklerose |
| US20040048779A1 (en) * | 2002-05-06 | 2004-03-11 | Erwin Schollmayer | Use of rotigotine for treating the restless leg syndrome |
| DE10220230A1 (de) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
| CA2496920A1 (en) | 2002-08-30 | 2004-03-11 | Kyowa Hakko Kogyo Co., Ltd. | Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| PT1426049E (pt) * | 2002-12-02 | 2005-09-30 | Sanol Arznei Schwarz Gmbh | Administracao iontoforetica de rotigotina para o tratamento da doenca de parkinson |
| US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
| CN102160865A (zh) | 2006-05-16 | 2011-08-24 | 诺普神经科学股份有限公司 | R(+)和s(-)普拉克索的组合物以及使用该组合物的方法 |
| WO2008009664A2 (en) * | 2006-07-19 | 2008-01-24 | Boehringer Ingelheim International Gmbh | Treatment of pain |
| US8524695B2 (en) | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
| JP2010521496A (ja) | 2007-03-14 | 2010-06-24 | ノップ ニューロサイエンシーズ、インク． | キラル精製置換ベンゾチアゾールジアミンの合成 |
| EP1987815A1 (en) * | 2007-05-04 | 2008-11-05 | Schwarz Pharma Ag | Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
| EP2334185A4 (en) | 2008-08-19 | 2011-09-21 | Knopp Neurosciences Inc | COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL |
| US9512096B2 (en) | 2011-12-22 | 2016-12-06 | Knopp Biosciences, LLP | Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
| WO2014105783A1 (en) * | 2012-12-28 | 2014-07-03 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine and clonidine |
| US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| SMT202100119T1 (it) | 2013-07-12 | 2021-05-07 | Knopp Biosciences Llc | Trattamento dei livelli elevati di eosinofili e/o basofili |
| US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
| ES2813674T3 (es) | 2013-08-13 | 2021-03-24 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b |
| EP3033081B1 (en) | 2013-08-13 | 2021-05-12 | Knopp Biosciences LLC | Compositions and methods for treating chronic urticaria |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3937271A1 (de) * | 1989-11-09 | 1991-05-16 | Boehringer Ingelheim Kg | Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol |
| DE4325491A1 (de) * | 1993-07-29 | 1995-02-02 | Boehringer Ingelheim Kg | Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels |
| US6001861A (en) * | 1998-01-16 | 1999-12-14 | Pharmacia & Upjohn Company | Use of pramipexole in the treatment of restless legs syndrome |
| DE19701619B4 (de) * | 1997-01-17 | 2007-10-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Pramipexol zur Behandlung des restless legs syndroms |
| WO2000054773A1 (en) * | 1999-03-12 | 2000-09-21 | Nitromed, Inc. | Dopamine agonists in combination with nitric oxide donors, compositions and methods of use |
-
1999
- 1999-08-19 DE DE19938825A patent/DE19938825A1/de not_active Withdrawn
-
2000
- 2000-08-09 PL PL00353358A patent/PL353358A1/xx not_active Application Discontinuation
- 2000-08-09 MX MXPA02001138A patent/MXPA02001138A/es unknown
- 2000-08-09 IL IL14774100A patent/IL147741A0/xx unknown
- 2000-08-09 CZ CZ2002515A patent/CZ2002515A3/cs unknown
- 2000-08-09 CA CA002376606A patent/CA2376606A1/en not_active Abandoned
- 2000-08-09 KR KR1020027002149A patent/KR20020060163A/ko not_active Withdrawn
- 2000-08-09 WO PCT/EP2000/007718 patent/WO2001013902A2/de not_active Ceased
- 2000-08-09 BR BR0013353-1A patent/BR0013353A/pt not_active Application Discontinuation
- 2000-08-09 AU AU64406/00A patent/AU6440600A/en not_active Abandoned
- 2000-08-09 JP JP2001518040A patent/JP2003507420A/ja active Pending
- 2000-08-09 EP EP00951485A patent/EP1210081A2/de not_active Withdrawn
- 2000-08-09 TR TR2002/00449T patent/TR200200449T2/xx unknown
- 2000-08-15 UY UY26293A patent/UY26293A1/es not_active Application Discontinuation
- 2000-08-17 PE PE2000000836A patent/PE20010642A1/es not_active Application Discontinuation
- 2000-08-18 AR ARP000104292A patent/AR025330A1/es unknown
- 2000-08-18 CO CO00062317A patent/CO5200840A1/es not_active Application Discontinuation
-
2001
- 2001-10-04 US US09/970,839 patent/US20020010201A1/en not_active Abandoned
-
2002
- 2002-02-18 NO NO20020793A patent/NO20020793L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL353358A1 (en) | 2003-11-17 |
| IL147741A0 (en) | 2002-08-14 |
| JP2003507420A (ja) | 2003-02-25 |
| DE19938825A1 (de) | 2001-04-26 |
| BR0013353A (pt) | 2002-04-23 |
| KR20020060163A (ko) | 2002-07-16 |
| PE20010642A1 (es) | 2001-06-08 |
| MXPA02001138A (es) | 2002-10-31 |
| NO20020793D0 (no) | 2002-02-18 |
| EP1210081A2 (de) | 2002-06-05 |
| CA2376606A1 (en) | 2001-03-01 |
| NO20020793L (no) | 2002-02-18 |
| CZ2002515A3 (cs) | 2002-05-15 |
| TR200200449T2 (tr) | 2002-08-21 |
| AU6440600A (en) | 2001-03-19 |
| WO2001013902A3 (de) | 2001-08-23 |
| AR025330A1 (es) | 2002-11-20 |
| WO2001013902A2 (de) | 2001-03-01 |
| US20020010201A1 (en) | 2002-01-24 |
| UY26293A1 (es) | 2001-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5200840A1 (es) | Combinacion de sustancias activas con clonidina | |
| ES2093735T3 (es) | Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica. | |
| AR111572A2 (es) | Formas farmacéuticas que contienen vardenafilo | |
| UY25544A1 (es) | Forma de dosificación de nefazodona | |
| NO20014724L (no) | Pregelatinisert stivelse i en formulering med regulert frigivning | |
| AR025329A1 (es) | Tratamiento medicamentoso del sindrome de piernas inquietas | |
| DE69225421D1 (de) | Sumatriptan enthaltende Arzneimittel | |
| CY1112361T1 (el) | Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743 | |
| ECSP055569A (es) | Forma de dosificación de pramipexol en una dosis única diaria | |
| AR033423A1 (es) | Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos | |
| ECSP066365A (es) | Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk | |
| UY27186A1 (es) | Formulación farmacéutica | |
| AR037629A1 (es) | Formulaciones farmaceuticas que comprenden un derivado de platino | |
| ES2092890T3 (es) | Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson. | |
| AR039633A2 (es) | Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica | |
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| UY27018A1 (es) | Derivados de la pirimidina | |
| UY27416A1 (es) | Uso de bibn4096 en combinación con otros fármacos antimigranosos para el tratamiento de migrana | |
| ECSP078014A (es) | Regimen de dosificacion para prasugrel | |
| AR031649A1 (es) | Composicion farmaceutica de dronedarona para administracion parenteral | |
| AR036877A1 (es) | Formulacion farmaceutica | |
| CO5271706A1 (es) | Unidad de dosis de mirtazapina para el tratamiento de transtornos del sueno | |
| AR042598A1 (es) | Composiciones de acetaminofeno | |
| AR037496A1 (es) | Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |